These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4305396)

  • 21. Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine.
    Pinto AA; Garland AJ
    J Hyg (Lond); 1979 Feb; 82(1):41-50. PubMed ID: 216744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses.
    Knudsen RC; Groocock CM; Andersen AA
    Infect Immun; 1979 Jun; 24(3):787-92. PubMed ID: 223986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trials of vaccination of pigs with vaccines of inactivated foot-and-mouth disease (FMD) virus. II. Trials with ethyl ethyleneimine (EEI) inactivated virus and diethylaminoethyl dextran as an adjuvant].
    Wittmann G; Bauer K; Mussgay M
    Arch Gesamte Virusforsch; 1970; 29(2):139-58. PubMed ID: 4316760
    [No Abstract]   [Full Text] [Related]  

  • 24. Neutralizing activity of sera from guinea-pigs inoculated with foot-and-mouth disease virus variants.
    Martinsen JS
    Res Vet Sci; 1972 Jan; 13(1):97-9. PubMed ID: 4336056
    [No Abstract]   [Full Text] [Related]  

  • 25. Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen.
    Hajam IA; Dar PA; Chandrasekar S; Nanda RK; Kishore S; Bhanuprakash V; Ganesh K
    Res Vet Sci; 2013 Dec; 95(3):936-41. PubMed ID: 23941960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.
    Wild TF; Brown F
    Arch Gesamte Virusforsch; 1968; 24(1):86-103. PubMed ID: 4301974
    [No Abstract]   [Full Text] [Related]  

  • 28. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
    Wittmann G
    Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
    [No Abstract]   [Full Text] [Related]  

  • 29. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
    Sakaki K; Suphavilai P; Chandarkeo T
    Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells.
    Meloen RH
    Arch Virol; 1976; 51(4):299-306. PubMed ID: 184763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 34. Two-plaque-size variants of foot-and-mouth disease virus differing in neutralization by guinea-pig antisera.
    Martinsen JS
    Res Vet Sci; 1971 Jul; 12(4):399-400. PubMed ID: 4326865
    [No Abstract]   [Full Text] [Related]  

  • 35. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serologic study of 2 strains of foot-and-mouth virus, cultured in cell line IB-RS-2, clone 26-3].
    Abuhab TG; Pinto AA
    Arq Inst Biol (Sao Paulo); 1978; 45(1):7-12. PubMed ID: 224836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foot-and-mouth disease virus in the llama (Lama glama): diagnosis, transmission, and susceptibility.
    Lubroth J; Yedloutschnig RJ; Culhane VK; Mikiciuk PE
    J Vet Diagn Invest; 1990 Jul; 2(3):197-203. PubMed ID: 1965585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
    Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
    Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the chemical structure and the biological activity of antibodies against the foot-and-mouth disease virus].
    Veleva EB
    Vet Med Nauki; 1977; 14(2):89-94. PubMed ID: 199988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
    Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
    Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.